UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000007082
Receipt number R000008342
Scientific Title The effect of Rho kinase inhibitor for the prevention of post-keratoplasty corneal endothelial cell loss
Date of disclosure of the study information 2012/02/01
Last modified on 2020/12/10 10:52:35

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

The effect of Rho kinase inhibitor for the prevention of post-keratoplasty corneal endothelial cell loss

Acronym

The effect of Rho kinase inhibitor for the prevention of post-keratoplasty corneal endothelial cell loss

Scientific Title

The effect of Rho kinase inhibitor for the prevention of post-keratoplasty corneal endothelial cell loss

Scientific Title:Acronym

The effect of Rho kinase inhibitor for the prevention of post-keratoplasty corneal endothelial cell loss

Region

Japan


Condition

Condition

Post-keratoplasty corneal endothelial cell loss

Classification by specialty

Ophthalmology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the efficacy of using Rho kinase inhibitor eye drops for the prevention of post-keratoplasty corneal endothelial cell loss

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Corneal endothelial cell density

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

Administration of Rho kinase inhibitor eye drops

Interventions/Control_2

Administration of vehicle

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Post keratoplasty
2. Obtainment of prior written informed consent

Key exclusion criteria

1. Pregnant or breast-feeding women
2. Patients with a psychological disorder or who could not comprehend instructions from the physician
3. Other criteria deemed improper for inclusion

Target sample size

40


Research contact person

Name of lead principal investigator

1st name Shigeru
Middle name
Last name Kinoshita

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Ophthalmology

Zip code

602-0841

Address

465 Hirokoji Kawaramachi Kamigyo-ku Kyoto, Japan 602-8566

TEL

075-221-2621

Email

shigeruk@koto.kpu-m.ac.jp


Public contact

Name of contact person

1st name Naoki
Middle name
Last name Okumura

Organization

Kyoto Prefectural University of Medicine

Division name

Department of Ophthalmology

Zip code

602-0841

Address

465 Hirokoji Kawaramachi Kamigyo-ku Kyoto, Japan 602-8566

TEL

075-251-5578

Homepage URL


Email

nokumura@koto.kpu-m.ac.jp


Sponsor or person

Institute

Department of Ophthalmology, Kyoto Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Department of Ophthalmology, Kyoto Prefectural University of Medicine

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kyoto Prefectural University of Medicine IRB

Address

465 Kajii-cho Kamigyou-ku Kyoto

Tel

075-251-5210

Email

rinri@koto.kpu-m.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

京都府立医科大学附属病院(京都府)、バプテスト眼科クリニック(京都府)


Other administrative information

Date of disclosure of the study information

2012 Year 02 Month 01 Day


Related information

URL releasing protocol

NA

Publication of results

Unpublished


Result

URL related to results and publications

NA

Number of participants that the trial has enrolled

10

Results

NA

Results date posted

2020 Year 12 Month 10 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

NA

Participant flow

NA

Adverse events

NA

Outcome measures

NA

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2011 Year 01 Month 17 Day

Date of IRB

2011 Year 01 Month 17 Day

Anticipated trial start date

2012 Year 02 Month 01 Day

Last follow-up date

2017 Year 02 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 01 Month 17 Day

Last modified on

2020 Year 12 Month 10 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000008342


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name